关键词：肽；化学连接氨基；有机化合物；生物活性；治疗剂
摘 要：Peptides are organic compounds that are composed of amino acids linked chemically by peptide bonds. They are the most potent biologically active substances found in nature and are used to trigger, control, and maintain an individual's physiological processes. However, using peptides as therapeutic agents was always difficult as they are qu instable and cannot pass through cellular membranes. They also require a specific technology to tackle extensive and challenging steps in their synthesis. Over 80 peptides are marketed by companies that explore the probabilities of designing and engineering peptides that can overcome their natural limits. They can be introduced as a treatment for chronic indications.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Overview of peptides

Peptide synthesis

Optimization of peptides

Stabilization of peptides

PART 06: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 07: Market segmentation based on route of

administration

Parenteral

Oral

Pulmonary

Mucosal

PART 08: Market segmentation by drug class

Somatostatins

Vasopressin

Calcitonins

Luteinizing hormone (LH)-releasing hormone (LHRH)

Glucagon and analogs

Insulins

Other

PART 09: Market segmentation by synthesis technology

Liquid-phase peptide synthesis

Solid-phase peptide synthesis

Hybrid peptide synthesis

PART 10: Geographical segmentation

Global peptide therapeutics market segmentation by

geography 2015-2020

Peptide therapeutics market in Americas

Peptide therapeutics market in EMEA

Peptide therapeutics market in APAC

PART 11: Market drivers

Increase in patient population

Advances in peptide synthesis technology

Promising pipeline

Unmet medical needs

Increase in healthcare spending

PART 12: Impact of drivers

PART 13: Market challenges

High cost of therapy

Adverse side effects

Stringent regulatory compliances

Intense market competition

PART 14: Impact of drivers and challenges

PART 15: Market trends

Growing popularity

Shifting focus toward untapped markets

Contract manufacturing

Increase in public awareness

PART 16: Vendor landscape

Competitive scenario

Eli Lilly

Novo Nordisk

Sanofi

Takeda Pharmaceutical

Teva Pharmaceuticals

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio